AZYRADA Trademark

Trademark Overview

On Tuesday, May 8, 2018, a trademark application was filed for AZYRADA with the United States Patent and Trademark Office. The USPTO has given the AZYRADA trademark a serial number of 87912394. The federal status of this trademark filing is ABANDONED - NO STATEMENT OF USE FILED as of Monday, January 10, 2022. This trademark is owned by Pfizer Inc.. The AZYRADA trademark is filed in the Pharmaceutical Products category with the following description:

anti-inflammatory pharmaceutical preparations, and pharmaceutical preparations for the treatment of autoimmune diseases, rheumatoid arthritis, plaque psoriasis, Crohn's disease, ulcerative colitis, psoriatic arthritis, ankylosing spondylitis, and juvenile idiopathic arthritis
azyrada

General Information

Serial Number87912394
Word MarkAZYRADA
Filing DateTuesday, May 8, 2018
Status606 - ABANDONED - NO STATEMENT OF USE FILED
Status DateMonday, January 10, 2022
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, October 9, 2018

Trademark Statements

Goods and Servicesanti-inflammatory pharmaceutical preparations, and pharmaceutical preparations for the treatment of autoimmune diseases, rheumatoid arthritis, plaque psoriasis, Crohn's disease, ulcerative colitis, psoriatic arthritis, ankylosing spondylitis, and juvenile idiopathic arthritis

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateThursday, May 17, 2018
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NamePfizer Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressNew York, NY 10017
Party NamePfizer Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressNew York, NY 10017

Trademark Events

Event DateEvent Description
Monday, January 10, 2022ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
Monday, January 10, 2022ABANDONMENT - NO USE STATEMENT FILED
Saturday, May 29, 2021NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Friday, May 28, 2021EXTENSION 5 GRANTED
Thursday, May 20, 2021EXTENSION 5 FILED
Thursday, May 27, 2021CASE ASSIGNED TO INTENT TO USE PARALEGAL
Thursday, May 20, 2021TEAS EXTENSION RECEIVED
Wednesday, October 28, 2020NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, October 26, 2020EXTENSION 4 GRANTED
Monday, October 26, 2020EXTENSION 4 FILED
Monday, October 26, 2020TEAS EXTENSION RECEIVED
Thursday, May 28, 2020NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, May 26, 2020EXTENSION 3 GRANTED
Tuesday, May 26, 2020EXTENSION 3 FILED
Tuesday, May 26, 2020TEAS EXTENSION RECEIVED
Tuesday, November 19, 2019NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Friday, November 15, 2019EXTENSION 2 GRANTED
Friday, November 15, 2019EXTENSION 2 FILED
Friday, November 15, 2019TEAS EXTENSION RECEIVED
Friday, May 24, 2019NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, May 22, 2019EXTENSION 1 GRANTED
Wednesday, May 22, 2019EXTENSION 1 FILED
Wednesday, May 22, 2019TEAS EXTENSION RECEIVED
Tuesday, December 4, 2018NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, October 9, 2018OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, October 9, 2018PUBLISHED FOR OPPOSITION
Wednesday, September 19, 2018NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Friday, August 31, 2018APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, August 29, 2018ASSIGNED TO EXAMINER
Thursday, May 17, 2018NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
Friday, May 11, 2018NEW APPLICATION ENTERED IN TRAM

Related Keywords

azyrada arthritis preparations pharmaceutical ulcerative colitis psoriatic spondylitis idiopathic juvenile disease